Dylan Beynon, CEO of Mindbloom, talks about why he started this company, the impact of Ketamine and MDMA therapy in our society, and how this industry is just going to grow bigger in the future.
TIME-STAMPED SHOW NOTES:
[00:00] – Know more about Dylan Beynon and his company, Mindbloom
[02:30] – Why did Dylan Beynon start Mindbloom
[06:22] – Dylan Beynon talks more about MDMA therapy
[13:30] – Pricing and treatment programs that Mindbloom offer
[15:30] – Dylan Beynon’s personal opinion on MDMA and Ketamine therapy
[22:12] – The largest peer review clinical study for psychedelic and ketamine therapy
[25:20] – The best mental health tool for Dylan Beynon
[27:53] – Dylan Beynon talks about Vipassana Meditation
[36:00] – Where to find Dylan Beynon and learn more about Mindbloom
Go to https://www.marketingschool.io to learn more!
Don’t forget to help us grow by subscribing and liking on YouTube!
Leave Some Feedback:
What should we talk about next? Please let us know in the comments below
Did you enjoy this episode? If so, please leave a short review.
Connect with Us:
Single Grain << Eric’s ad agency
NP Digital << Neil’s ad agency
X @neilpatel
X @ericosiu
Discover Latest Episodes
Hosted by Neil and Eric, this episode dives into real-world CRO workflows, using Spiralyze-style A/B test insights to guide changes, and rapid AI prototyping with Alloy.app to keep designs on-brand wi...
In this episode, Eric and Neil break down the evolution of SEO into GEO, AEO, and LLMO, and why marketers must adapt to shifting client demands. They explore how platforms like Reddit and YouTube now ...
In this episode #3042, Eric and Neil break down the competitive landscape and market positioning, the role of personalization in advertising, and hiring strategies that spotlight candidates with prove...